Pediatric Endocrinology

Latest News

Genomic Testing Can Help Diagnose Children Born SGA With Persistent Short Stature

By

Roxanne Nelson, BSN, RN

Genomic testing using next-generation sequencing may be advantageous in diagnosing patients born small for gestational age with persistent short stature.

Safety and Mortality Outcomes Following Pediatric Growth Hormone Therapy

By

Endocrinology Advisor Contributing Writer

Primary cancer rates and mortality risk were no higher for pediatric patients treated with growth hormone therapy.

Higher Risk for Meningioma Linked to GH Treatment, Radiotherapy During Childhood

By

Roxanne Nelson, BSN, RN

The risk for meningioma was not significantly higher in patients who did not receive radiotherapy.

Grote Clinical Decision Rule May Be Best for Monitoring Growth in Children

By

Endocrinology Advisor Contributing Writer

Investigators sought to improve growth-monitoring programs by examining existing algorithms and examined the effect of using WHO vs national growth charts on algorithm performance.

Following Approval, Triptorelin 6-Month Injection Now Available to Treat Central Precocious Puberty

By

Da Hee Han, PharmD

Gonadotropin-releasing hormone (GnRH) agonist Triptodur treats central precocious puberty via intramuscular injection.

FDA: Triptorelin Slows Central Precocious Puberty

By

Compiled by Lauren Biscaldi

Data from a phase 3 clinical trial found that triptorelin achieved positive results in patients age 2 and older with central precocious puberty.

Growth Hormone Does Not Impact Glucose Homeostasis in Turner Syndrome

By

Jeff Craven

Treatment with growth hormone did not affect insulin sensitivity or insulin secretion in girls with Turner syndrome.

Precocious Puberty More Common in Girls Than Boys

By

Jason Harris

Ovarian cyst and McCune-Albright syndrome were most responsible for the increased risk of non-congenital adrenal hyperplasia gonadotropin-independent precocious puberty.

Metformin Linked to Increased Height in Children, Teens

In larger doses, the diabetes drug may increase height in children and adolescents.

Longer-Term Histrelin Safe, Effective for Central Precocious Puberty

By

Melissa Foster Digital Content Editor

Long-term treatment with the histrelin implant safely and effectively sustained gonadotropin suppression and improved predicted adult height in central precocious puberty.

Ferring to Launch Pediatric Endo Products Zomacton and Zoma-Jet Soon

By

Da Hee Han, PharmD

Ferring announced that the FDA has approved the name changes of its newly acquired products to be marketed as Zomacton (somatropin [rDNA origin]; formerly Tev-Tropin) for injection, and the needle-free delivery system as Zoma-Jet (formerly Tjet).